Phenol
As of the edition of 20 October 2026, Phenol is a small molecule: marketed, first approved in 1963 (CA).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1982
- Kind
- Small molecule
- Brand name
- Glycerinated Phenol Saline
- First approved
- 31 December 1963 (CA)
- Approvals on record
- 3 in 2 regions
- Holder of the most recent approval
- Stallergenes; 2 holders in all
- Withdrawn from market
- 1 January 1983 (in some regions)
- Registered trials
- 8, 1 stopped early
- Disease areas
- Bones, joints and muscles; Cancer
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 3 | 1 | 0 | 0 |
| Phase 1 | 1 | 0 | 0 | 0 |
| Phase 4 | 4 | 1 | 0 | 1 |
| All trials | 8 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Alk-Abello | Applicant | 1963 to now |